RXSIGHT INC's ticker is and the CUSIP is 78349D107. A total of 54 filers reported holding RXSIGHT INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $115,000 | +85.5% | 4,099 | +89.1% | 0.00% | – |
Q2 2023 | $62,000 | +67.6% | 2,168 | -4.0% | 0.00% | – |
Q1 2023 | $37,000 | -24.5% | 2,259 | -42.0% | 0.00% | – |
Q4 2022 | $49,000 | +1533.3% | 3,896 | +1452.2% | 0.00% | – |
Q3 2022 | $3,000 | +50.0% | 251 | +116.4% | 0.00% | – |
Q2 2022 | $2,000 | -84.6% | 116 | -89.2% | 0.00% | – |
Q1 2022 | $13,000 | -68.3% | 1,078 | -70.4% | 0.00% | – |
Q4 2021 | $41,000 | +24.2% | 3,646 | +39.5% | 0.00% | – |
Q3 2021 | $33,000 | – | 2,614 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Divisadero Street Capital Management, LP | 680,000 | $18,965,200 | 5.98% |
NEXT CENTURY GROWTH INVESTORS LLC | 747,827 | $20,856,895 | 2.27% |
Parkman Healthcare Partners LLC | 381,331 | $10,635,322 | 1.95% |
Atika Capital Management LLC | 509,352 | $14,205,828 | 1.86% |
RA Capital Management | 3,052,796 | $85,142,480 | 1.68% |
EAM Investors, LLC | 163,168 | $4,550,756 | 0.88% |
No Street GP LP | 250,000 | $6,972,500 | 0.83% |
ADVISORY RESEARCH INC | 156,189 | $4,356,112 | 0.60% |
Lisanti Capital Growth, LLC | 123,205 | $3,436,187 | 0.54% |
Alpha DNA Investment Management LLC | 20,879 | $582,315 | 0.24% |